182 related articles for article (PubMed ID: 25738323)
1. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
3. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.
Mostoslavsky G; Fabian AJ; Rooney S; Alt FW; Mulligan RC
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16406-11. PubMed ID: 17062750
[TBL] [Abstract][Full Text] [Related]
4. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.
Multhaup M; Karlen AD; Swanson DL; Wilber A; Somia NV; Cowan MJ; McIvor RS
Hum Gene Ther; 2010 Jul; 21(7):865-75. PubMed ID: 20163250
[TBL] [Abstract][Full Text] [Related]
8. Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells.
Rivière J; Hauer J; Poirot L; Brochet J; Souque P; Mollier K; Gouble A; Charneau P; Fischer A; Pâques F; de Villartay JP; Cavazzana M
Gene Ther; 2014 May; 21(5):529-32. PubMed ID: 24622732
[TBL] [Abstract][Full Text] [Related]
9. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
[TBL] [Abstract][Full Text] [Related]
11. A non-leaky Artemis-deficient mouse that accurately models the human severe combined immune deficiency phenotype, including resistance to hematopoietic stem cell transplantation.
Xiao Z; Dunn E; Singh K; Khan IS; Yannone SM; Cowan MJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):1-11. PubMed ID: 19135937
[TBL] [Abstract][Full Text] [Related]
12. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
14. Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency.
Carbonaro DA; Zhang L; Jin X; Montiel-Equihua C; Geiger S; Carmo M; Cooper A; Fairbanks L; Kaufman ML; Sebire NJ; Hollis RP; Blundell MP; Senadheera S; Fu PY; Sahaghian A; Chan RY; Wang X; Cornetta K; Thrasher AJ; Kohn DB; Gaspar HB
Mol Ther; 2014 Mar; 22(3):607-622. PubMed ID: 24256635
[TBL] [Abstract][Full Text] [Related]
15. Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning.
Huston MW; van Til NP; Visser TP; Arshad S; Brugman MH; Cattoglio C; Nowrouzi A; Li Y; Schambach A; Schmidt M; Baum C; von Kalle C; Mavilio F; Zhang F; Blundell MP; Thrasher AJ; Verstegen MM; Wagemaker G
Mol Ther; 2011 Oct; 19(10):1867-77. PubMed ID: 21750532
[TBL] [Abstract][Full Text] [Related]
16. Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells.
Lesniak MS; Kelleher E; Pardoll D; Cui Y
Neurol Res; 2005 Dec; 27(8):820-6. PubMed ID: 16354542
[TBL] [Abstract][Full Text] [Related]
17. Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene.
van Til NP; de Boer H; Mashamba N; Wabik A; Huston M; Visser TP; Fontana E; Poliani PL; Cassani B; Zhang F; Thrasher AJ; Villa A; Wagemaker G
Mol Ther; 2012 Oct; 20(10):1968-80. PubMed ID: 22692499
[TBL] [Abstract][Full Text] [Related]
18. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
Adjali O; Marodon G; Steinberg M; Mongellaz C; Thomas-Vaslin V; Jacquet C; Taylor N; Klatzmann D
J Clin Invest; 2005 Aug; 115(8):2287-95. PubMed ID: 16075064
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral Gene Therapy for Artemis-Deficient SCID.
Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
[TBL] [Abstract][Full Text] [Related]
20. Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis.
Serafini M; Bonamino M; Golay J; Introna M
Haematologica; 2004 Jan; 89(1):86-95. PubMed ID: 14754610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
